Results 291 to 300 of about 578,532 (358)

Sustained Atrial Fibrillation by Acetylcholine Infusion into the Sinus Node Artery

, 1968
Koichi Nakayama, Yasuyuki Suzuki, Koroku Hashimoto   +2 more
openalex   +2 more sources

Biobank-driven genomic discovery yields new insight into atrial fibrillation biology

Nature Genetics, 2018
J. Nielsen, Rosa B. Thorolfsdottir, L. Fritsche, Wei Zhou, M. W. Skov, S. Graham, T. Herron, S. McCarthy, Ellen M. Schmidt, Gardar Sveinbjornsson, I. Surakka, M. Mathis, M. Yamazaki, Ryan D. Crawford, M. Gabrielsen, A. Skogholt, O. Holmen, Maoxuan Lin, B. Wolford, Rounak Dey, H. Dalen, P. Sulem, Jonathan H. Chung, J. Backman, D. Arnar, U. Thorsteinsdóttir, A. Baras, C. O’Dushlaine, A. Holst, Xiaoquan Wen, W. Hornsby, F. Dewey, M. Boehnke, S. Kheterpal, B. Mukherjee, Seunggeun Lee, H. Kang, H. Hólm, J. Kitzman, J. Shavit, J. Jalife, C. Brummett, Tanya M. Teslovich, D. Carey, D. Gudbjartsson, K. Stefánsson, G. Abecasis, K. Hveem, C. Willer   +48 more
semanticscholar   +1 more source

Incidence of stroke in patients with atrial fibrillation undergoing surgical treatment: a meta-analysis. [PDF]

BMC Cardiovasc Disord
Lin D, Cheng Y, Yu S, Liu X, Yan C, Cheng W.   +5 more
europepmc   +1 more source

A Study on The Experimental Production of Atrial Fibrillation

, 1966
Yasushi Oka
openalex   +2 more sources

Lipid metabolism-associated metabolites on cardiovascular diseases: a two-sample Mendelian randomized study. [PDF]

Front Cardiovasc Med
Chen JL, Lu XY, Chen DZ, Chen Y.
europepmc   +1 more source

EFFECTS OF ACETYLCHOLINE AND ADRENALINE ON THE ATRIAL FIBRILLATION

, 1965
Masayosi GOTO, Tadasi Tamai
openalex   +2 more sources

Use of Real‐World Claims Data to Assess the Prevalence of Concomitant Medications to Inform Drug–Drug Interaction Risk in Target Patient Populations

Clinical Pharmacology &Therapeutics, EarlyView.
A common issue in clinical drug development involves drug–drug interactions (DDI) that may lead to altered drug exposure and subsequent altered safety and efficacy of an investigational drug or concomitant medications (conmeds) in the target patient population.
Alice S. Tang, Logan Brooks, Denise M. Boudreau, Pascal Chanu, Amita Joshi, Bianca Vora, Rui Zhu   +6 more
wiley   +1 more source

Author response: "Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: a systematic review and meta-analysis". [PDF]

Eur Stroke J
Palaiodimou L, Tsivgoulis G.
europepmc   +1 more source

Ventricular Response in Atrial Fibrillation

, 1965
Richard Langendorf, Alfred Pick, Louis N. Katz   +2 more
openalex   +1 more source

Impact of Age and Factor Xa Inhibitor Concentrations on Bleeding Risk in Patients with Atrial Fibrillation

Clinical Pharmacology &Therapeutics, EarlyView.
This study aimed to analyze differences in the exposure‐response relationship for factor Xa inhibitors (FXaI) between patients aged ≥ 80 and < 80 years. Patients with atrial fibrillation (AF) taking rivaroxaban, apixaban, or edoxaban were enrolled, and a single steady‐state trough concentration was measured.
Shin‐Yi Lin, Yen‐Bing Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Sung‐Chun Tang, Jiann‐Shing Jeng   +7 more
wiley   +1 more source